Pharma News, 2020

(Reuters) - Japan’s Sosei Group Corp will collaborate with AbbVie Inc on a drug discovery partnership that could be worth up to $1 billion.

Local health officials and the World Health Organization today finally declared the end of an outbreak of Ebola that had plagued the Democratic Republic of the Congo in Africa for nearly two years.

A researcher at the University of San Diego, California (USCD) made an accidental discovery several years back after he silenced a gene called PTB in mouse fibroblasts, cells in connective tis...

Merck is willing to spend $500 million-plus on a deal that sees it gain access to a clutch of Yumanity’s neurodegenerative disease drugs.

BEIJING, June 23 (Xinhua) -- Chinese researchers have revealed that the asymptomatic infections of the novel coronavirus disease (COVID-19) have a weaker immune response compared with ...

Cyclica started out licensing its drug-design software to biopharma companies, but it quickly realized that route was “simply not inspiring.

Gilead Sciences’ infused antiviral remdesivir currently holds an FDA emergency use authorization to treat severe hospitalized COVID-19 patients.

In the race between two pharma giants in a multibillion-dollar field, Merck Monday posted two trial wins.

PARIS (Reuters) - French drugmaker Sanofi (SASY.

Novartis has terminated its sponsored hydroxychloroquine clinical trial for COVID-19 due to acute enrolment challenges that have made trial completion “infeasible”.

(Reuters) - Gilead Sciences Inc expects supply of its potential COVID-19 drug remdesivir to exceed two million courses by year-end, the company said on Monday, more than double its previous ta...

BEIJING (Reuters) - China’s capital will see a “cliff-like” drop in new cases in a recent outbreak of the novel coronavirus by the end of this week with efforts to cut chains of transmis...